Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Demetra H Hufnagel

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Urogynecology (Philadelphia, Pa.)|March 19, 2026
Modified Delphi Consensus Guidelines for Pelvic Floor Botulinum Toxin InjectionDemetra H Hufnagel, Michele Torosis, A Lenore Ackerman
International Journal of Molecular Sciences|November 4, 2020
Platelets, Thrombocytosis, and Ovarian Cancer Prognosis: Surveying the Landscape of the LiteratureDemetra H Hufnagel, Gabriella D Cozzi, Marta A Crispens, et al.
Cancer Epidemiology|August 26, 2021
Increasing Area Deprivation Index negatively impacts ovarian cancer survivalDemetra H Hufnagel, Dineo Khabele, Fiona E Yull, et al.
Biomarker Research|September 25, 2020
Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosisDemetra H Hufnagel, Andrew J Wilson, Jamie Saxon, et al.
Journal of Autism and Developmental Disorders|November 19, 2010
The Ritvo Autism Asperger Diagnostic Scale-Revised (RAADS-R): a scale to assist the diagnosis of Autism Spectrum Disorder in adults: an international validation studyRiva Ariella Ritvo, Edward R Ritvo, Donald Guthrie, et al.
BMC Cancer|October 8, 2020
Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancerAlyssa A Hoover, Demetra H Hufnagel, Whitney Harris, et al.
BMC Cancer|May 5, 2022
Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancerEvan B Glass, Alyssa A Hoover, Kennady K Bullock, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Urogynecology (Philadelphia, Pa.)|March 19, 2026
Modified Delphi Consensus Guidelines for Pelvic Floor Botulinum Toxin InjectionDemetra H Hufnagel, Michele Torosis, A Lenore Ackerman
International Journal of Molecular Sciences|November 4, 2020
Platelets, Thrombocytosis, and Ovarian Cancer Prognosis: Surveying the Landscape of the LiteratureDemetra H Hufnagel, Gabriella D Cozzi, Marta A Crispens, et al.
Cancer Epidemiology|August 26, 2021
Increasing Area Deprivation Index negatively impacts ovarian cancer survivalDemetra H Hufnagel, Dineo Khabele, Fiona E Yull, et al.
Biomarker Research|September 25, 2020
Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosisDemetra H Hufnagel, Andrew J Wilson, Jamie Saxon, et al.
Journal of Autism and Developmental Disorders|November 19, 2010
The Ritvo Autism Asperger Diagnostic Scale-Revised (RAADS-R): a scale to assist the diagnosis of Autism Spectrum Disorder in adults: an international validation studyRiva Ariella Ritvo, Edward R Ritvo, Donald Guthrie, et al.
BMC Cancer|October 8, 2020
Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancerAlyssa A Hoover, Demetra H Hufnagel, Whitney Harris, et al.
BMC Cancer|May 5, 2022
Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancerEvan B Glass, Alyssa A Hoover, Kennady K Bullock, et al.
Pageof 1